Materias dentro de su búsqueda.
Mostrando 2,981 - 3,000 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.45s Limitar resultados
  1. 2981
    “…Herein, a phosphorothioate backbone modification strategy was applied to regulate the biomedical properties of pancreatic cancer cell–targeting aptamer for efficient in vivo drug delivery. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Regulating the properties of XQ-2d for targeted delivery of therapeutic agents to pancreatic cancers
  2. 2982
    “…KEY POINTS: • Current state of radiomics research in pancreatic cancer shows low software compliance to the Image Biomarker Standardisation Initiative (IBSI). • IBSI-compliant radiomics studies in pancreatic cancer are heterogeneous and not comparable, and the majority of study designs showed low reproducibility. • Improved methodology and standardisation of practice in the emerging field of radiomics has the potential of this non-invasive imaging biomarker in the management of pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings
  3. 2983
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center
  4. 2984
    “…BACKGROUND: Pancreatic cancer is one of the leading causes of cancer death in Western societies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo
  5. 2985
    “…Background: Pancreatic cancer is one of the deadliest forms of cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic cancer grading in pathological images using deep learning convolutional neural networks
  6. 2986
    “…The current investigation evaluated the predictive significance and underlying processes of PKP3 within pancreatic cancer (PC) tissues. The assessment of differences in PKP3 expression was conducted through an analysis of RNA-seq data acquired from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis
  7. 2987
    “…Background and Objectives: PNU-74654, a Wnt/β-catenin pathway inhibitor, has an antiproliferative effect on many cancer types; however, its therapeutic role in pancreatic cancer (PC) has not yet been demonstrated. Here, the effects of PNU-74654 on proliferation and cell cycle phase distribution were studied in PC cell lines. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer
  8. 2988
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
  9. 2989
    “…Pancreatic cancer is one of the most challenging cancers due to its high mortality rates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
  10. 2990
    “…Pancreatic cancer (PC) has one of the lowest survival rates among all major types of cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identifying Effective Biomarkers for Accurate Pancreatic Cancer Prognosis Using Statistical Machine Learning
  11. 2991
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment
  12. 2992
    “…OBJECTIVES: A retrospective study was conducted to evaluate the efficacy of coagulation parameters in differentiating pancreatic cancer/early stage pancreatic cancer (EPC, TNM stages I and II) from benign control conditions, and to further explore whether coagulation parameters could improve the differential value of CA199. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Coagulation parameters for the differential diagnosis of pancreatic cancer in the early stage: a retrospective study
  13. 2993
    “…PURPOSE: Pancreatic cancer is one of the most aggressive malignant tumors with poor prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk factors for unresectable pancreatic cancer following high‐intensity focused ultrasound treatment
  14. 2994
    “…CONCLUSION: The possible causes of rhabdomyolysis in this patient with pancreatic cancer are discussed, the development of paraneoplastic myopathy being the most likely. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature
  15. 2995
    “…We analyzed the immune microenvironment in pancreatic cancer tumor tissue samples from patients treated with neoadjuvant therapy compared to patients after upfront surgery to gain knowledge about the immunological environment after therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer
  16. 2996
    “…Pancreatic cancer is characterized by a poor prognosis, with its five-year survival rate lower than that of any other cancer type. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
  17. 2997
    “…Meanwhile, curcumin maintains high intracellular Ca(2+) to further suppress HSP-chaperone ATP by disrupting mitochondrial Ca(2+) homeostasis. Therefore, pancreatic cancer is triple-sensitized to IR780-mediated PTT. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer
  18. 2998
    “…Early detection of pancreatic cancer is crucial for improving patient outcomes, and identifying reliable biomarkers is a critical research area in this field. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Unveiling the potential of galectin-3 as a diagnostic biomarker for pancreatic cancer: a review
  19. 2999
    “…Analysis of published single‐cell RNA‐sequencing data for human pancreatic cancer tissue revealed that COL17A1 was expressed predominantly in cancer cells rather than surrounding stromal cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment
  20. 3000
    “…To demonstrate the impact of genetics and pharmacogenetics on PDAC disparities, a review of the literature was performed using PubMed with variations of the following keywords: pharmacogenetics, pancreatic cancer, race, ethnicity, African, Black, toxicity, and the FDA-approved drug names: Fluoropyrimidines, Topoisomerase inhibitors, Gemcitabine, Nab-Paclitaxel, Platinum agents, Pembrolizumab, PARP-inhibitors, and NTRK fusion inhibitors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans
Herramientas de búsqueda: RSS